News
BWAY
14.43
+0.14%
0.02
BrainsWay Reports One-Year Durability Data for SWIFT Deep TMS in Major Depression
TipRanks · 8h ago
BrainsWay Presents New Prospective 12-Month Durability Data Demonstrating Sustained Clinical Benefits Following Accelerated Deep Transcranial Magnetic Stimulation For Major Depressive Disorder
Benzinga · 8h ago
BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting
Barchart · 13h ago
Weekly Report: what happened at BWAY last week (0601-0605)?
Weekly Report · 1d ago
Brainsway Chief Scientist Yiftach Roth sells 7,000 common shares for NIS 301,087.01
PUBT · 6d ago
Weekly Report: what happened at BWAY last week (0525-0529)?
Weekly Report · 06/01 09:33
Brainsway director Ety Mitrany sells shares worth NIS 813,177.37
PUBT · 05/26 20:03
Brainsway Price Target Raised to $17.00/Share From $15.00 by HC Wainwright & Co.
Dow Jones · 05/26 10:51
Brainsway Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/26 10:51
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $17
Benzinga · 05/26 10:41
Brainsway price target raised to $17 from $15 at H.C. Wainwright
TipRanks · 05/26 10:16
Weekly Report: what happened at BWAY last week (0518-0522)?
Weekly Report · 05/25 09:35
BrainsWay Takes Minority Stake in Hopemark Health to Expand Deep TMS Footprint
TipRanks · 05/18 11:58
Brainsway announces $1.5M investment in APS Innovations
TipRanks · 05/18 11:48
BrainsWay To Invest $1.5M Initially, With Potential For Additional $1.5M Via Milestone-Based Investments, For Minority Position In Hopemark In Form Of Preferred, Annually Compounding Security
Benzinga · 05/18 11:33
BrainsWay invests $1.5 million for minority stake in Hopemark Health
PUBT · 05/18 11:30
BRAINSWAY LTD - AGREEMENT INCLUDES REDEMPTION MECHANISM FOR SHARES
Reuters · 05/18 11:30
Weekly Report: what happened at BWAY last week (0511-0515)?
Weekly Report · 05/18 09:35
BrainsWay Announces Minority-Stake Investment in Hopemark Health
Barchart · 05/18 06:30
More
Webull provides a variety of real-time BWAY stock news. You can receive the latest news about Brainsway Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About BWAY
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.